Boca Raton, FL -- (SBWIRE) -- 10/21/2013 -- StockFreak scours the market on a daily basis looking for the hottest penny stocks that may be the next big runners. StockFreak focuses on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks - J.C. Penney Company, Inc. (NYSE:JCP), Golden Star Resources Ltd. (USA) (NYSEMKT:GSS), FreeSeas Inc (NASDAQ:FREE), Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX)
J.C. Penney Company, Inc. (NYSE:JCP) ended lower -4.76% and complete the day at $7.00. The total number of shares changed hands during the day was 52.99million. After opening at $7.40, the stock hit as high as $7.45. However, it traded between $6.97 and $26.83 over the last twelve months. J. C. Penney Company, Inc., through its subsidiary, J. C. Penney Corporation, Inc., operates department stores. The company sells family apparel and footwear, accessories, fine and fashion jewelry, beauty products, and home furnishings.
Has JCP Found The Bottom and Ready To Move Up? Find Out Here
Golden Star Resources Ltd. (USA) (NYSEMKT:GSS) closed yesterday at $0.442, a -6.16% decrease. Around 2.23 million shares were traded, low from an-average trading volume of 3.76 million shares. The company is now valued at around $114.52 million. Golden Star Resources Ltd. engages in the acquisition, exploration, development, and operation of gold properties. The company primarily owns and operates the Bogoso/Prestea gold mining and processing operations that cover approximately 40 kilometers of strike along the southwest-trending Ashanti gold district in Western Ghana.
Has GSS Found The Bottom And Ready To Gain Momentum? Find Out Here
FreeSeas Inc (NASDAQ:FREE) moved -16.60 percent lower at $0.417 and traded between $0.39 and $0.52 after opening the day at $0.51. Its performance over the last five days remained -26.91%, which stands at -13.84% for a month. Going back further than one month, 1-year performance after recent close was -52.56%. FreeSeas Inc., through its subsidiaries, provides drybulk shipping services. Its vessels carry various drybulk commodities, including iron ore, grain, and coal, as well as bauxite, phosphate, fertilizers, steel products, cement, sugar, and rice. As of December 31, 2012, the company owned and operated six Handysize dry bulk carriers and one Handymax dry bulk carrier.
Why Should Investors Buy FREE After the Recent Fall? Just Go Here and Find Out
Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX)’s shares dropped -27.20 percent to close at $1.90. The stock is up around +336.78% this year and +14.46% for the last 12 months. Around 9.98 million shares changed hands yesterday, higher from an-average trading volume of 2.68 million shares. Catalyst Pharmaceutical Partners, Inc. operates as development-stage specialty pharmaceutical company. It focuses on the development and commercialization of novel prescription drugs targeting rare (orphan) neuromuscular and neurological diseases and disorders.
Will CPRX Get Buyers Even After The Recent Rally? Find Out Here
StockFreak scours the market on a daily basis looking for the hottest penny stocks that may be the next big runners. We strive to provide you with only the most opportunistic picks by pouring over mountains of data and charts. How often we send out our alerts is dependent on how often we find something worthwhile.
GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY THE FOLLOWING NOTICE AND DISCLAIMER MUST BE READ AND UNDERSTOOD AND YOU MUST AGREE TO THE TERMS CONTAINED THEREIN BEFORE USING THIS WEBSITE OR SUBSCRIBING TO OUR NEWSLETTER.
We are engaged in the business of advertising and promoting companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Neither the owner of StockFreak.com nor any of its members, officers, directors, contractors or employees are licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed on StockFreak.com. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. StockFreak.com makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website.
StockFreak.com has been retained by an unrelated third party to perform promotional and advertising services for a limited time with respect to the company we are profiling or discussing on this website and in exchange for such services has received cash compensation from such third party. Questions regarding this website may be sent to info@StockFreak.com.
Read Our Disclaimer at: http://www.stockfreak.com/disclaimer.html
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)